Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor

Human Antibodies

Volumn 8, Issue 2, 1997, Pages 60-64

  Udayachander, Myleru ^a   Dean, Christopher J ^b   Meenakshi, Anantha Narayanan ^a   Sivakumar, Nallathambi ^a   Babu, Polani Balasubramaniam Ramesh ^a   Sivakumar, Jayabalan ^a  

^a CANCER INSTITUTE WIA   (India)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Antitumor activity; CIBCNSH3; EGF receptor; Monoclonal antibody

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOPEROXIDASE STAINING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; TUMOR IMMUNITY; TUMOR VOLUME;

EID: 0030799211     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-1997-8202     Document Type: Article

References (17)

1. Filmus J, Trent JM, Pollak MN, Buick RN. Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants. Mol Cell Biol 1987; 7: 251
2. Sainsbury JRC, Malcolm AJ, Appleton DR, Farndon JR, Harris AL. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 1985; 38: 1225
3. Goustin AS, Leof EB, Shipley GD, Moses HL. Growth factors and cancer. Cancer Res 1986; 46: 1015
4. Wynford Thomas D. Oncogenes and anti-oncogenes: The molecular basis of tumor behaviors. J Pathol 1991; 165: 187
5. Nicholson S, Richard J, Sainsbury C, et al. Epidermal growth factor receptor (EGFR) results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Br J Cancer 1991; 63: 146
6. Modjtahedi H, Eccles S, Box G, Styles J, Dean C. Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction. Br J Cancer 1993; 67: 254
7. Modjtahedi H, Eccles SA, Box G, Styles J, Dean CJ. Antitumor activity of combinations of antibodies directed against different epitopes on the extracellular domain of the human EGF receptor. Cell Biophysics 1993; 22: 129
8. Modjrahedi H, Styles JM, Dean CJ. The human EGF receptor as a target for cancer therapy: Six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468. Br J Cancer 1993; 67: 247
9. Dean C, Midjtahedi H, Eccles S, Box G, Styles J. Immunotherapy with antibodies to the EGF receptor. Int J Cancer Supplement 1994; 8: 103
10. Jones W, Choongkittaworn N, Hosick HL, Dils R, Hallowes RC. Isolation of epithelial subcomponents of the mouse mammary gland for tissue level culture studies. J Tissue Cult Meth 1983; 8: 17
11. Ennis BW, Valverius EM, Bates SE, Lippman ME, Bellot F, Kris R, Schlessinger J, Masui H, Goldenberg A, Mendelsohn J, Dickinson RB. Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells. Mol Endocrinol 1989; 3: 1830
12. Gullick WJ, Marsden JJ, Whittle N, Ward B, Bobrow L, Waterfield MD. Expression of epidermal growth factor receptors on human cervical, ovarian and vulva carcinomas. Cancer Res 1986; 46: 285
13. Harris AL, Nicholson S, Sainsbury R, Wright C, Farndon JR. Epidermal-growth factor receptor and other oncogenes as prognostic markers. J Nat Cancer Inst Monogr 1992; 11: 181
14. Dean CJ, Styles JM, Gyure LA, Peppard J, Hobbs SM, Jackson E, Hall JG. The production of hybridomas from the gut associated lymphoid tissue of tumour bearing rats. I. Mesenteric nodes as a source of IgG producing cells. Clin Exp Immunol 1984; 57: 358
15. Mendelsohn J. The epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies. Cancer Biol 1990; 1: 339
16. Ennis BW, Lippman ME, Dickson RB. The EGF receptor system as a target for anti tumour therapy. Cancer Invest 1991; 9: 553
17. Divgi CR, West S, Kris M, et al. Phase 1 and imaging trial of indium III-labelled anti-EGF receptor antibody 225 in patients with squamous cell lung carcinomas. J Nat Cancer Inst 1991; 83: 97